.svg){kind=small}
Mar-2026
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Attune has demonstrated a consistent performance in the Topical category in Massachusetts, maintaining a steady second-place ranking from December 2025 through March 2026. This stability in the rankings suggests a strong brand presence and consumer loyalty within the state. Despite a dip in sales in February 2026, where they reached $17,666, Attune rebounded in March 2026 with sales climbing back to $25,824. This recovery indicates a resilient market strategy that effectively addresses fluctuations in consumer demand.
While Attune's performance in Massachusetts is commendable, it is important to note that the brand does not feature in the top 30 rankings in other states or categories during the same period. This absence could be seen as a limitation in their market reach or a strategic focus on the Massachusetts market. The lack of presence in other states might suggest potential areas for growth or an opportunity for Attune to expand its footprint beyond its current stronghold. Observing how Attune navigates these dynamics in the coming months could provide insights into their strategic priorities and market adaptation tactics.
Competitive Landscape
In the Massachusetts topical cannabis market, Attune consistently held the second rank from December 2025 through March 2026, showcasing its strong market presence. Despite maintaining its position, Attune faces stiff competition from Treeworks, which has consistently held the top rank with significantly higher sales figures. Meanwhile, Chill Medicated and Doctor Solomon's trail behind Attune in third and fourth positions, respectively. Notably, Doctor Solomon's was absent from the top 20 in January 2026, indicating potential volatility in its market standing. Attune's sales saw a notable increase in March 2026, suggesting a positive trend and potential for further growth, even as it remains a step behind Treeworks in terms of overall sales volume.
Notable Products
In March 2026, the top-performing product for Attune was the CBD/THC 1:1 Muscle Freeze Lotion (75mg CBD, 75mg THC) in the Topical category, maintaining its number one rank consistently from December 2025. The Muscle Freeze Lotion (100mg THC, 30ml) also held its second position, showing a significant sales increase to 463 units. The CBD/THC 1:1 Muscle Freeze Lotion (50mg CBD, 50mg THC) rose to third place from fourth in February, demonstrating a notable improvement in sales. Meanwhile, the CBD/THC 1:1 Muscle Freeze (69mg CBD, 66mg THC) slipped to fourth, after being third for the previous months. The CBD/THC 1:2 Muscle Freeze Lotion (30mg CBD, 60mg THC) remained in fifth place, with sales figures remaining steady.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
